Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision tag on the page changed from v3.6.2 to v3.6.3, signaling a new version of the document. There is no indication of a change to the visible content of the study record.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating an updated page revision. This reflects a metadata update rather than a change to the study information itself.SummaryDifference0.0%

- Check38 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'); the Intervention/Treatment label was updated and the revision/version updated from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a new release of the site components.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision has been updated from v3.5.3 to v3.5.4, signaling a new revision of the document. This appears to be a minor, non-user-facing update rather than a change to content or features.SummaryDifference0.0%

- Check74 days agoChange DetectedTaoyuan District, Taiwan, 333423 was updated to Taoyuan, Taiwan, 333423 in the locations list. The postal code remains 333423.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.